Author

D. J. Crona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

C. D. Torrice· 2 shared C. R. M. Asquith· 2 shared C. Alamillo-Ferrer· 1 shared C. Grundner· 1 shared G. J. Tizzard· 1 shared K. A. Maffuid· 1 shared K. M. Koshlap· 1 shared N. Fleck· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

C. D. Torrice

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines

C. R. M. Asquith, N. Fleck, C. D. Torrice, D. J. Crona, C. Grundner, W. J. Zuercher

The paper identifies novel anti-tubercular compounds from 4-anilinoquinolines and 4-anilinoquinazolines with high potency and low toxicity.

bioRxiv · Jun 18, 2019Pharmacology & Toxicology

Design and evaluation of novel 4-anilinoquinolines and quinazolines as EGFR inhibitors in lung cancer and chordoma

C. R. M. Asquith, K. A. Maffuid, T. Laitinen, C. D. Torrice, G. J. Tizzard, C. Alamillo-Ferrer, K. M. Koshlap, D. J. Crona, W. Zuercher

The paper designs and evaluates novel 4-anilinoquinolines and quinazolines as EGFR inhibitors, identifying a potent compound for lung cancer and chordoma treatment.

bioRxiv · Feb 11, 2019 · PreprintPharmacology & Toxicology